Breaking News

Lonza Launches Capsugel Zephyr DPI Portfolio

Includes a portfolio of high-quality, customizable DPI capsules of different polymers and compositions, and product customization services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza has launched Capsugel Zephyr, a new dry-powder inhalation (DPI) capsule portfolio for customized solutions for optimal pulmonary drug delivery. Lonza’s Capsule Delivery Solutions developed Capsugel Zephyr capsules as a portfolio of high-quality, highly customizable DPI capsules of different polymers and compositions, and product customization services to help address the specific needs of inhalation drug products manufacturers.   “Capsule-based DPI technology is quickly becoming th...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters